Related Experiment Videos
Retinal ganglion cell shrinkage in glaucoma
1Department of Ophthalmology, University Hospital of Wales, Heath Park, Cardiff, United Kingdom. morganje3@cardiff.ac.uk
Journal of Glaucoma
|August 10, 2002
Summary
Early glaucoma may involve selective loss of retinal ganglion cells in the magnocellular pathway. Cell shrinkage, not just cell death, may explain apparent selective damage in glaucoma research.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- The selective loss of retinal ganglion cells (RGCs) in the magnocellular pathway during early glaucoma remains debated.
- Histologic studies suggest larger RGCs are preferentially lost, implying magnocellular pathway damage, but psychophysical evidence is lacking.
Purpose of the Study:
- To investigate the morphological changes in RGCs during experimental glaucoma.
- To determine if cell shrinkage contributes to the apparent selective loss of magnocellular RGCs.
Main Methods:
- Analysis of RGC morphology in experimental glaucoma models.
- Quantitative assessment of cell volume, axon diameter, and dendritic tree size.
Main Results:
- RGCs exhibit morphological changes, including reduced cell volume, prior to cell death in experimental glaucoma.
- Surviving RGCs show significant shrinkage, affecting axon and dendritic tree dimensions.
- These changes are consistent with cell shrinkage explaining previously reported selective damage.
Conclusions:
- Cell shrinkage is a likely explanation for the apparent selective loss of magnocellular RGCs in early glaucoma.
- Widespread morphological alterations in the RGC population precede cell death and influence overall RGC function.